Safety Modeling and Profiling, Immune-Related Adverse Events
Learn about the cutting edge of computational immuno-oncology through a partnership between NCI and the Society for Immunotherapy of Cancer (SITC)!
Join Dr. Marcelo Pasquini of the Medical College of Wisconsin and Dr. Alan Hutson of the Roswell Park Comprehensive Cancer Center as they discuss their understanding and prediction of adverse immune reactions associated with medical interventions, such as immunotherapy and immune-modulating drugs.
This webinar explores the development of safety models (using diverse data sources) to identify potential risk factors and patterns of immune-related adverse events, including:
- genetic markers,
- immune system profiling, and
- patient histories.
The SITC-NCI Computational Immuno-Oncology Webinar Series features eight, one-hour-long webinars designed to educate early-career scientists on computational immuno-oncology, increase participants’ awareness of and engagement in NCI-supported Cancer MoonshotSM Immunotherapy Networks, and fulfill the Blue Ribbon Panel’s goal of accelerating progress in cancer research.
Dr. Pasquini is a professor at the Medical College of Wisconsin. His clinical focus is on the treatment of patients with hematologic malignancies, largely multiple myeloma.
Dr. Hutson serves as chair of the Biostatistics and Bioinformatics Department and associate director of the Biostatistics and Statistical Genomics Shared Resource at Roswell Park Comprehensive Cancer Center.